139 related articles for article (PubMed ID: 9722299)
1. Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger C; Böhler T; Karawajew L; Ludwig WD; Schrappe M; Debatin KM
Br J Haematol; 1998 Aug; 102(3):722-8. PubMed ID: 9722299
[TBL] [Abstract][Full Text] [Related]
2. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
Beltinger C; Kurz E; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Blood; 1998 May; 91(10):3943-51. PubMed ID: 9573033
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines.
Dirks W; Schöne S; Uphoff C; Quentmeier H; Pradella S; Drexler HG
Br J Haematol; 1997 Mar; 96(3):584-93. PubMed ID: 9054667
[TBL] [Abstract][Full Text] [Related]
5. [The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].
Beltinger C; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Klin Padiatr; 1998; 210(4):153-8. PubMed ID: 9743945
[TBL] [Abstract][Full Text] [Related]
6. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.
Karawajew L; Wuchter C; Ruppert V; Drexler H; Gruss HJ; Dörken B; Ludwig WD
Leukemia; 1997 Aug; 11(8):1245-52. PubMed ID: 9264377
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
Zhou M; Gu L; Yeager AM; Findley HW
Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
[TBL] [Abstract][Full Text] [Related]
9. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.
Huang QR; Morris D; Manolios N
Mol Immunol; 1997 Jun; 34(8-9):577-82. PubMed ID: 9393960
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis.
Posovszky C; Friesen C; Herr I; Debatin KM
Leukemia; 1999 Mar; 13(3):400-9. PubMed ID: 10086731
[TBL] [Abstract][Full Text] [Related]
13. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
14. Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer.
Boldrini L; Faviana P; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Pingitore F; Fontanini G
Int J Oncol; 2002 Jan; 20(1):155-9. PubMed ID: 11743657
[TBL] [Abstract][Full Text] [Related]
15. Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.
Scholl V; Stefanoff CG; Hassan R; Spector N; Renault IZ
Leuk Lymphoma; 2007 May; 48(5):957-63. PubMed ID: 17487740
[TBL] [Abstract][Full Text] [Related]
16. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
17. CD95 antigen mutations in hematopoietic malignancies.
Landowski TH; Moscinski L; Burke R; Buyuksal I; Painter JS; Goldstein S; Dalton WS
Leuk Lymphoma; 2001; 42(5):835-46. PubMed ID: 11697638
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
19. ATM promoter analysis in childhood lymphoid malignancies: a brief communication.
Gumy-Pause F; Wacker P; Maillet P; Betts DR; Sappino AP
Leuk Res; 2006 Mar; 30(3):335-7. PubMed ID: 16125772
[TBL] [Abstract][Full Text] [Related]
20. Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene.
Müschen M; Re D; Betz B; Moers C; Wolf J; Niederacher D; Diehl V; Beckmann MW
Int J Cancer; 2001 Apr; 92(2):309-10. PubMed ID: 11291062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
